Who
Sri Kosuri
Director
Company insider
Files Form 4 as: Director, Ginkgo Bioworks Holdings.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 Nov 2024
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 11 Jun 2026filed 15 Jun 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 12 Jun 2025filed 13 Jun 2025 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,375 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —24,067 | filing |
| 11 Jun 2025filed 13 Jun 2025 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —24,067 | filing |
| 6 Nov 2024filed 8 Nov 2024 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,240 at $0.00 | filing |
| 6 Nov 2024filed 8 Nov 2024 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,911 at $0.00 | filing |
| 6 Nov 2024filed 8 Nov 2024 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,067 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.